| Medical and Health Sciences | Lifetime | 541 | US 292 | 99.98 |
| Economics and Finance | Lifetime | 821 | US 457 | 99.48 |
| Oncology | Lifetime | 38 | US 21 | 99.93 |
| Pediatrics, Perinatology and Child Health | Lifetime | 108 | US 52 | 99.67 |
| Econometrics and Quantitative Economics | Lifetime | 458 | US 273 | 99.54 |
| Pulmonary and Respiratory Medicine | Lifetime | 276 | US 150 | 99.66 |
| Genetics | Lifetime | 795 | US 409 | 98.04 |
| Cancer Research | Lifetime | 503 | US 265 | 96.86 |
| Oncology | 2021-2025 | 162 | US 73 | 98.76 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 227 | US 83 | 95.51 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 421 | US 135 | 95.57 |
| Statistics and Probability | 2021-2025 | 386 | US 173 | 64.76 |
| Family Support in Illness | Lifetime | 1 | US 1 | 99.91 |
| Cancer survivorship and care | Lifetime | 2 | US 2 | 99.95 |
| Cancer-related cognitive impairment studies | Lifetime | 1 | US 1 | 99.86 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 7 | US 6 | 99.89 |
| Economic and Financial Impacts of Cancer | Lifetime | 6 | US 6 | 99.85 |
| Global Cancer Incidence and Screening | Lifetime | 39 | US 16 | 99.60 |
| Palliative Care and End-of-Life Issues | Lifetime | 50 | US 27 | 99.57 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 106 | US 52 | 99.59 |
| Cancer Treatment and Pharmacology | Lifetime | 190 | US 106 | 99.41 |
| BRCA gene mutations in cancer | Lifetime | 93 | US 49 | 99.13 |
| Breast Cancer Treatment Studies | Lifetime | 191 | US 100 | 99.36 |
| Patient-Provider Communication in Healthcare | Lifetime | 84 | US 34 | 98.78 |
| Multiple and Secondary Primary Cancers | Lifetime | 109 | US 49 | 98.54 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 73 | US 40 | 97.56 |
| Brain Metastases and Treatment | Lifetime | 156 | US 101 | 98.72 |
| Estrogen and related hormone effects | Lifetime | 439 | US 262 | 98.34 |
| Cancer Risks and Factors | Lifetime | 205 | US 104 | 98.42 |
| Glioma Diagnosis and Treatment | Lifetime | 752 | US 393 | 97.93 |
| Menopause: Health Impacts and Treatments | Lifetime | 147 | US 104 | 97.01 |
| Advances in Oncology and Radiotherapy | Lifetime | 646 | US 313 | 90.32 |
| Cancer-related cognitive impairment studies | 2021-2025 | 1 | US 1 | 98.92 |
| Cancer survivorship and care | 2021-2025 | 13 | US 6 | 99.30 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 57 | US 39 | 98.45 |
| Family Support in Illness | 2021-2025 | 40 | US 13 | 96.36 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 188 | US 119 | 94.17 |
| Breast Cancer Treatment Studies | 2021-2025 | 752 | US 265 | 92.09 |
| Cancer Treatment and Pharmacology | 2021-2025 | 498 | US 181 | 90.66 |
| BRCA gene mutations in cancer | 2021-2025 | 516 | US 232 | 88.09 |
| Global Cancer Incidence and Screening | 2021-2025 | 776 | US 333 | 89.57 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 137 | US 32 | 84.75 |
